These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20731837)

  • 1. Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated.
    Park SY; Kim YM; Pyo H
    Mol Cancer; 2010 Aug; 9():222. PubMed ID: 20731837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.
    Storozhuk Y; Hopmans SN; Sanli T; Barron C; Tsiani E; Cutz JC; Pond G; Wright J; Singh G; Tsakiridis T
    Br J Cancer; 2013 May; 108(10):2021-32. PubMed ID: 23632475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
    Cariveau MJ; Tang X; Cui XL; Xu B
    Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest.
    Lundholm L; Hååg P; Zong D; Juntti T; Mörk B; Lewensohn R; Viktorsson K
    Cell Death Dis; 2013 Jan; 4(1):e478. PubMed ID: 23370278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGK733 does not inhibit ATM or ATR kinase activity in H460 human lung cancer cells.
    Choi S; Toledo LI; Fernandez-Capetillo O; Bakkenist CJ
    DNA Repair (Amst); 2011 Oct; 10(10):1000-1; author reply 1002. PubMed ID: 21865098
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
    Golding SE; Rosenberg E; Valerie N; Hussaini I; Frigerio M; Cockcroft XF; Chong WY; Hummersone M; Rigoreau L; Menear KA; O'Connor MJ; Povirk LF; van Meter T; Valerie K
    Mol Cancer Ther; 2009 Oct; 8(10):2894-902. PubMed ID: 19808981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated.
    Cowell IG; Durkacz BW; Tilby MJ
    Biochem Pharmacol; 2005 Dec; 71(1-2):13-20. PubMed ID: 16293233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
    Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
    Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effection and mechanism of radiosensitivity of non-small cell lung cancer cell line H358 following gefitinib treatment].
    Deng J; Zhuang L; Chen Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):841-7. PubMed ID: 22104217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer.
    Rho JK; Choi YJ; Ryoo BY; Na II; Yang SH; Kim CH; Lee JC
    Cancer Res; 2007 Feb; 67(3):1163-9. PubMed ID: 17283151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib.
    Morgillo F; Kim WY; Kim ES; Ciardiello F; Hong WK; Lee HY
    Clin Cancer Res; 2007 May; 13(9):2795-803. PubMed ID: 17473213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ataxia-telangiectasia mutated by antisense oligonucleotide nanoparticles induces radiosensitization of head and neck squamous-cell carcinoma in mice.
    Zou J; Qiao X; Ye H; Zhang Y; Xian J; Zhao H; Liu S
    Cancer Biother Radiopharm; 2009 Jun; 24(3):339-46. PubMed ID: 19435407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.
    Huang Y; Chen Y; Mei Q; Chen Y; Yu S; Xia S
    Oncol Rep; 2013 Jun; 29(6):2486-92. PubMed ID: 23525575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.
    Tracy S; Mukohara T; Hansen M; Meyerson M; Johnson BE; Jänne PA
    Cancer Res; 2004 Oct; 64(20):7241-4. PubMed ID: 15492241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage caused by metal nanoparticles: involvement of oxidative stress and activation of ATM.
    Wan R; Mo Y; Feng L; Chien S; Tollerud DJ; Zhang Q
    Chem Res Toxicol; 2012 Jul; 25(7):1402-11. PubMed ID: 22559321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.
    Li N; Li H; Su F; Li J; Ma X; Gong P
    Int J Clin Exp Pathol; 2015; 8(8):9010-20. PubMed ID: 26464643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persimmon leaf extract inhibits the ATM activity during DNA damage response induced by Doxorubicin in A549 lung adenocarcinoma cells.
    Kawakami K; Nishida H; Tatewaki N; Nakajima Y; Konishi T; Hirayama M
    Biosci Biotechnol Biochem; 2011; 75(4):650-5. PubMed ID: 21512242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.
    Engelman JA; Jänne PA; Mermel C; Pearlberg J; Mukohara T; Fleet C; Cichowski K; Johnson BE; Cantley LC
    Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3788-93. PubMed ID: 15731348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.